- Country: Russia
- Summary: Purchase of Drugs on 1folding 2022
- RUT Ref No: 60921552
- Deadline: 15 Dec 2021
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 88739.66
- Notice Type: Tender
- Document Ref. No.: 0346300119921000130
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Lot Name: - Bismuth Triklia Ditrate Tablets Covered with film shell 120mg.
Activated carbon tablet 250 mg.
Algecedrat + magnesium hydroxide chewing tablets.
Aluminum phosphate gel for intakes in 16 g №20.
Domperidon Tablets (or pills covered with shell, or tablets for resorption) 10 mg.
Sodium amidotrizoate solution for injection 760 mg / ml 20 ml.
Papaverin solution for injection 20 mg / ml2 ml №10.
Tablet trimetutin 100 mg №10.
Ezomeprazole Tablets covered with a shell (or capsules (or tablet filled with film shell) intestinal soluble)) 20 mg. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPurchase of Drugs on 1folding 2022 - Russia Tender
The STATE HEALTHCARE INSTITUTION "LIPETSK CITY CHILDREN'S HOSPITAL", a Government sector organization in Russia, has announced a new tender for Purchase of Drugs on 1folding 2022. This tender is published on RussiaTenders under RUT Ref No: 60921552 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-12-15.
The estimated tender value is RUB 88739.66, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
